BioMed Realty Trust, Inc. (BMR) Tops Q2 FFO by 4c

BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $171.16 million versus the consensus estimate of $160.8 million.

For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
• SeaStar Medical (ICU) Misses Q1 EPS by 4c